Our Pricing

Understanding the Mounjaro Price Decrease in the UK

Published: 10 September 2026

The recent mounjaro price decrease has made tirzepatide weight loss treatment more accessible to UK patients seeking clinically proven weight management solutions. At Cured Pharmacy, Mounjaro is now available from £124.99, with an additional £20 off your first order using code Weightlossnew, bringing your starting price to just £124.99. This price reduction reflects increased market availability and our commitment to offering the lowest prices guaranteed across the UK.

What's Behind the Mounjaro Price Decrease?

The mounjaro price decrease observed across UK pharmacies stems from improved supply chain stability and increased market competition following the medication's successful launch for weight management. Mounjaro (tirzepatide) received MHRA approval for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities, leading to expanded distribution networks and more competitive pricing structures [1].

Clinical demand for tirzepatide has grown substantially following the publication of the SURMOUNT-1 trial, which demonstrated that participants achieved an average weight reduction of 20.9% of body weight over 72 weeks on the highest dose [2]. This robust efficacy data, combined with the medication's dual GIP/GLP-1 receptor agonist mechanism, has positioned Mounjaro as a premium weight loss option. The recent price decrease makes this evidence-based treatment more accessible without compromising the quality of UK-licensed medication dispensed by our GPhC-registered pharmacy.

At Cured Pharmacy, our transparent pricing model ensures you see the exact cost before completing your clinical assessment. Unlike some providers who reveal pricing only after consultation, we display our competitive rates upfront, with Mounjaro starting from £124.99 and further reduced to £124.99 with your first-order discount code Weightlossnew.

How the Mounjaro Price Decrease Compares to Other Weight Loss Treatments

When evaluating the mounjaro price decrease in context, it's essential to compare tirzepatide's cost-effectiveness against alternative weight management medications available in the UK. While Mounjaro represents a premium investment, the magnitude of weight loss achieved in clinical trials often exceeds that of single-receptor GLP-1 agonists like semaglutide [3].

The SURMOUNT-1 trial showed that 89% of participants on the 15mg dose achieved at least 5% body weight reduction, with 57% achieving 20% or greater weight loss [2]. This compares favourably to semaglutide trials, though individual response varies based on adherence, lifestyle modifications, and metabolic factors. The price decrease makes Mounjaro's superior efficacy profile more financially accessible for patients who may benefit from dual-receptor agonism.

Cost Per Kilogram of Weight Loss

From a pharmacoeconomic perspective, the mounjaro price decrease improves the cost-per-kilogram calculation for weight loss. Based on SURMOUNT-1 data showing average weight reductions of 15-20.9% depending on dose, a patient weighing 100kg might expect to lose 15-21kg over 72 weeks [2]. At £124.99 per month (or £124.99 with discount code), the annualised cost divided by expected weight loss can represent reasonable value for those seeking maximal weight reduction outcomes, subject to individual clinical response and prescriber approval.

Accessing the Mounjaro Price Decrease at Cured Pharmacy

To benefit from the mounjaro price decrease at Cured Pharmacy, patients must complete a brief online clinical assessment reviewed by our UK-registered prescribers. This ensures tirzepatide is clinically appropriate based on your BMI, medical history, and current medications. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees all dispensing to guarantee you receive genuine UK-licensed Mounjaro KwikPens.

The assessment process takes under three minutes and covers essential medical information including cardiovascular history, thyroid conditions, and concurrent medications that may interact with GLP-1 receptor agonists [4]. Once approved, your prescription is fulfilled using authentic Eli Lilly Mounjaro pens, delivered in 100% discreet packaging directly to your UK address. All prescription treatments require clinical assessment and approval by a qualified UK prescriber before dispensing.

Applying Your £10 Discount Code

The mounjaro price decrease is further enhanced by our first-order discount code Weightlossnew, which reduces your initial treatment cost by £124.99. Simply enter this code at checkout after completing your clinical assessment to bring your starting price down to £124.99. This discount applies to your first Mounjaro order and can be combined with our already competitive base pricing of £124.99 per treatment cycle.

Clinical Efficacy Justifying the Mounjaro Price Decrease

The mounjaro price decrease makes a highly effective treatment more accessible to UK patients who meet clinical criteria. Tirzepatide's dual incretin action—activating both GIP and GLP-1 receptors—produces synergistic effects on insulin secretion, glucagon suppression, and appetite regulation that translate to superior weight loss outcomes compared to single-receptor agonists [1].

In the SURMOUNT-2 trial involving participants with type 2 diabetes, tirzepatide 15mg produced a mean weight reduction of 14.7% compared to 3.2% with placebo over 72 weeks [5]. The medication's ability to delay gastric emptying, reduce energy intake, and improve glycaemic control makes it particularly valuable for patients with obesity and metabolic comorbidities. These robust clinical outcomes, now available at reduced cost, represent significant value for appropriate candidates.

Safety Considerations Despite the Mounjaro Price Decrease

While the mounjaro price decrease improves affordability, safety remains paramount when initiating tirzepatide therapy. Common adverse effects include gastrointestinal symptoms such as nausea, diarrhoea, and vomiting, which typically diminish over the initial weeks as tolerance develops [4]. Dose escalation following the recommended titration schedule helps minimise these effects.

Contraindications include personal or family history of medullary thyroid carcinoma and multiple endocrine neoplasia syndrome type 2. Patients should be counselled on recognising symptoms of pancreatitis, including severe abdominal pain radiating to the back, and instructed to discontinue treatment and seek immediate medical attention if such symptoms occur [1]. Our clinical team reviews all medical histories during the online assessment to identify any contraindications before approving treatment.

At Cured Pharmacy, we provide comprehensive patient information leaflets with every Mounjaro dispensing, ensuring you understand proper injection technique, storage requirements (refrigeration at 2-8°C), and when to contact your healthcare provider. The price decrease does not compromise the quality of clinical oversight or pharmaceutical care you receive from our GPhC-registered team.

Maximising Value from the Mounjaro Price Decrease

To optimise outcomes following the mounjaro price decrease, combine tirzepatide therapy with evidence-based lifestyle modifications including reduced-calorie nutrition and increased physical activity. Clinical trials demonstrating 15-20% weight loss included dietary counselling and exercise recommendations as standard components of the intervention [2].

Regular monitoring of weight, BMI, and metabolic parameters helps track progress and ensures treatment remains clinically beneficial. Patients should maintain communication with their prescriber regarding efficacy and tolerability, as dose adjustments may be necessary to balance weight loss outcomes with gastrointestinal side effects. The cost savings from the price decrease can be reinvested in supportive measures such as nutritional counselling or fitness programmes to enhance overall results.

Long-Term Cost Planning

The mounjaro price decrease enables more sustainable long-term treatment planning for chronic weight management. Most clinical trials assessed tirzepatide efficacy over 72 weeks, with some participants continuing therapy beyond this timeframe to maintain weight loss [5]. At £124.99 per month (£124.99 with first-order discount), patients can budget approximately £124.99 annually for ongoing treatment, subject to continued clinical appropriateness and prescriber approval. This investment should be weighed against the health benefits of sustained weight reduction, including improvements in cardiovascular risk factors, glycaemic control, and obesity-related comorbidities.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 10 September 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 10 September 2026]
3. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 10 September 2026]
4. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating obesity: Technology appraisal guidance. NICE. [accessed 10 September 2026]
5. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2023). Two-year effects of tirzepatide on obesity and glycaemic control: SURMOUNT-2 trial. The Lancet Diabetes & Endocrinology, 11(9), 658-670. [accessed 10 September 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 10 September 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 10 September 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 10 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.